- ISIN
- US70805E1091
- CUSIP
- 70805E109
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Oct 1, 2019
Highlights
- Market Cap
- $1.20B
- Enterprise Value
- $1.67B
- EPS (TTM)
- $0.86
- PE Ratio
- 39.33
- PEG Ratio
- 0.41
- Total Revenue (TTM)
- $1.02B
- Gross Profit (TTM)
- $113.88M
- EBITDA (TTM)
- $58.23M
- Year Range
- $21.73 - $37.54
- Target Price
- $39.00
- ROA (TTM)
- 3.17%
- ROE (TTM)
- 8.76%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PNTG Performance Chart
The Pennant Group, Inc. (PNTG) is up 19.5% since the beginning of the year. At $34 per share, PNTG is trading 10.4% below its 52-week high of $38. Investors who bought $1,000 worth of PNTG shares 5 years ago would now be looking at an investment worth $806.
Loading charts...
Returns By Period
The Pennant Group, Inc. (PNTG) has returned 19.47% so far this year and 21.06% over the past 12 months.
The Pennant Group, Inc.
- 1D
- 0.57%
- 1M
- -0.85%
- YTD
- 19.47%
- 6M
- 14.19%
- 1Y
- 21.06%
- 3Y*
- 40.29%
- 5Y*
- -4.21%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PNTG Monthly Returns History
Based on dividend-adjusted daily data since Oct 1, 2019, PNTG's average daily return is +0.21%, while the average monthly return is +4.63%. At this rate, an investment would double in approximately 1.3 years.
Historically, 56% of months were positive and 44% were negative. The best month was Oct 2019 with a return of +192.5%, while the worst month was Mar 2020 at -47.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.
On a daily basis, PNTG closed higher 52% of trading days. The best single day was Oct 1, 2019 with a return of +145.4%, while the worst single day was Mar 18, 2020 at -25.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.88% | 22.05% | -9.58% | 2.76% | 9.36% | -1.81% | 19.47% | ||||||
| 2025 | -0.19% | -13.98% | 10.45% | 1.87% | 12.06% | 3.97% | -25.73% | 8.30% | 5.04% | -1.94% | 12.01% | 1.62% | 6.15% |
| 2024 | 7.83% | 24.25% | 5.25% | 6.52% | 12.58% | -1.49% | 28.55% | 14.93% | 4.20% | -10.45% | -2.47% | -14.95% | 90.52% |
| 2023 | 17.85% | 16.07% | -4.93% | -2.87% | -13.48% | 2.33% | -6.51% | 4.36% | -7.10% | -2.34% | 26.22% | 1.46% | 26.78% |
| 2022 | -27.99% | -2.23% | 14.65% | -12.02% | 16.72% | -33.04% | 4.14% | 17.47% | -33.57% | 18.25% | -16.00% | 6.19% | -52.43% |
| 2021 | -7.39% | -1.84% | -13.22% | -11.75% | -15.22% | 19.35% | -16.33% | -10.67% | -8.11% | -8.97% | -20.49% | 13.53% | -60.25% |
Benchmark Metrics
The Pennant Group, Inc. has an annualized alpha of 41.63%, beta of 1.16, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since October 01, 2019.
- This stock captured 237.79% of S&P 500 Index gains and 156.55% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 41.63%
- Beta
- 1.16
- R²
- 0.08
- Upside Capture
- 237.79%
- Downside Capture
- 156.55%
Return for Risk
Risk / Return Rank
PNTG ranks 58 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for The Pennant Group, Inc. (PNTG) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PNTG | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.50 | ||
| Sortino ratioReturn per unit of downside risk | -1.75 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.37 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.81 | 2.78 | -1.97 |
| Martin ratioReturn relative to average drawdown | 1.67 | 12.44 | -10.77 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the The Pennant Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the The Pennant Group, Inc. was 86.27%, occurring on Oct 12, 2022. The portfolio has not yet recovered.
The current The Pennant Group, Inc. drawdown is 49.41%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -86.27%Oct 2022 | 1y 9mo | — | 5y 5moJan 2021 - now |
COVID crash2020 | -70.99%Mar 2020 | 2mo 26d | 4mo 27d | 7mo 23dDec 2019 - Aug 2020 |
2019 bear market2019 | -21.05%Nov 2019 | 1mo 4d | 5d | 1mo 9dOct 2019 - Nov 2019 |
2020 bear market2020 | -20.36%Sep 2020 | 22d | 1mo 12d | 2mo 4dAug 2020 - Oct 2020 |
2020 pullback2020 | -9.62%Nov 2020 | 1d | 12d | 13dNov 2020 - Dec 2020 |
Drawdown Indicators
| PNTG | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.27% | -56.78% | -29.49% |
Max Drawdown (1Y)Largest decline over 1 year | -26.06% | -9.10% | -16.96% |
Max Drawdown (3Y)Largest decline over 3 years | -40.16% | -18.90% | -21.26% |
Max Drawdown (5Y)Largest decline over 5 years | -78.52% | -25.43% | -53.09% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -49.41% | -1.80% | -47.61% |
Average DrawdownAverage peak-to-trough decline | -55.71% | -10.71% | -45.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.62% | 2.03% | +10.59% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of The Pennant Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how The Pennant Group, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PNTG, comparing it with other companies in the Medical Care Facilities industry. Currently, PNTG has a P/E ratio of 39.3. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PNTG compared to other companies in the Medical Care Facilities industry. PNTG currently has a PEG ratio of 0.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PNTG relative to other companies in the Medical Care Facilities industry. Currently, PNTG has a P/S ratio of 1.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PNTG in comparison with other companies in the Medical Care Facilities industry. Currently, PNTG has a P/B value of 3.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PNTG
Add The Pennant Group, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PNTG